InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Fickenscher James E, Chief Financial Officer. Insider active across 1 companies, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been logged. The latest transaction was filed on 26 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
085,000 shares0
Common Stock
SEC:0001062993-22-001785:0·
085,000 shares0
Common Stock
SEC:0001062993-22-001785·
2 of 2 declarations
About Fickenscher James E
James E. Fickenscher is the Chief Financial Officer at Zynerba Pharmaceuticals, Inc. In this role, he oversees the financial management of the company, ensuring compliance and efficiency in financial operations.
